go-v.orgdoi

Will preoperative trials change future clinical practice?

Elgene Lim, Eric P. Winer · Clinical Investigation · 2011

  • DOI 10.4155/cli.10.3
  • Publisher OMICS Publishing Group
  • Type article
  • Issued 2011

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Clinical Investigation · OMICS Publishing Group · article · 2011

Abstract

Preoperative systemic therapy (PST) has emerged from an infrequently used approach in the management of patients with breast cancer to one with an established role in both inoperable and operable breast cancer. In particular, it now has an established role in drug development and biomarker discovery programs. In this era of molecular-based therapies, the unique resource of paired pre- and post-treatment tissue in PST trials represents a powerful research tool for the in vivo study of biologic mechanisms of systemic therapy.

It is possible to examine downregulation of signaling pathways that are known to be activated, and off-target effects through the identification of pathways not previously known to be activated. In addition, correlative studies may identify predictive biomarkers of response and resistance, which has the potential to inform the design of larger and more expensive adjuvant trials. The aims of this article are to review key developments in PST trials, particularly in specific breast cance...

Open the resolved locator · 10.4155/cli.10.3

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 21:28 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://doi.org/10.4155/cli.10.3
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.